• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Raising the Bar for COVID-19 Data Integrity and Disease Surveillance

Share:

September 16, 2020

Just a few weeks ago, the mood among technologists in the Coronavirus pandemic remained cautiously optimistic about reopening society with the help of testing data, contact tracing apps, and other IT-enabled resources. But the recent spike in illness – 1.9 million new US cases in July, more than double any other month – is a sobering reboot on a crisis we now understand needs far more IT and data coordination than previously recognized.

The emerging consensus among epidemiologists is that testing and contact tracing alone are no longer sufficient to contain the virus at its current rate of transmission. Instead, many are calling for more coordination and resources to collect and manage disease data on both a national and international level.

Let’s take a closer look at the ways IT providers can best support these enhanced requirements – and how success involves nudging Health IT architectures and processes to be more strategic, coordinated, and standardized with data they use in the fight against COVID-19.

A “National Weather Service” Model for Data-Driven Disease Surveillance

The troubling spike in COVID-19 cases is proof we need more testing, but the challenge has gone far beyond just that. Many contact tracing efforts deployed in conjunction with testing have stumbled; and even though new contact tracing apps continue to hit the market, some experts now view even the best of such efforts as “moot” given the current volume, velocity, and severity of the spread.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

It’s clear we need a higher level of coordination – something Johns Hopkins University epidemiologist Caitlin Rivers likened in a recent Foreign Affairs article to “the contagion equivalent of the National Weather Service” – to get, and then manage, large sets of public health data streaming into agency servers. It’s an apt analogy, given how each use case involves information that is changeable and geographically disperses; consists of vast amounts of structured and unstructured data; and involves life or death consequences when data is poorly managed.

It’s also clear that, while some authoritarian countries can mandate the gathering of personal health information in disease surveillance, any globally-relevant IT strategy will need to rely on buy-in from the public, and do so on an international scale to match the scope of the pandemic. “The winning approaches in technology are going to be the ones that realize the underlying challenge is a cultural one – with your solution designed around the realities of a stressed out, fearful population whose buy-in you’re going to need,” said George Mason University global health expert Gary L. Kreps, Ph.D., FAAHB, in an interview for this article.

Dr. Kreps, who also served as founding chief of the National Cancer Institute’s Health Communication and Informatics Research Branch from 1999 to 2004, currently runs an international research consortium that provides 15 different countries with culturally adapted versions NCI’s Health Information National Trends Survey (HINTS). “Especially in a global crisis like this, you need to position health information within an atmosphere of trust and transparency,” he told me. “Show what’s successful, help governments and populations around the world to understand what goes into that success, and then encourage them to model and apply that success in ways that make sense locally to them.”

The good news is that, especially when rendered as part of a scientifically sound and culturally sensitive strategy, the right health IT practices and systems can effectively support the new levels of coordination and efficiency we are going to need for advanced COVID-19 disease modeling.

Faster, Better, Data-Driven Disease Surveillance

As I mentioned, our most immediate and outsized priority is better collection, standardization, and reporting of data. Unfortunately, research led by former CDC Director Thomas Friden found that states are reporting only 40-percent of the data needed to fight the pandemic in the first place. Further, once data is collected, statisticians claim gaps in data infrastructure present hurdles to its full analysis.

Such shortcomings must be addressed to improve standardization and alignment of both the gathering and analysis of data. This will require not just better data standardization, but also improved governance and quality assurance as data courses throughout the entire system or product lifecycle. I’ve often mentioned the ANSI-accredited Fast Healthcare Interoperability Resources (FHIR) framework as a step in the right direction. Process improvement and better IT records management will also help. And we should abide throughout to ensure reproducible research so processes can be repeatable and scalable – especially when large data sets are involved.

These improvements in how we collect and manage data will lay a more solid foundation for both basic analysis and more advanced AI and ML applications that power real-time mapping of cases, mobile app interventions, estimates of unreported infections, and other advanced processes. Such capabilities energize people like Robert Jennings, Executive Director of the CDC-affiliated National Public Health Information Coalition. “The more complete and coordinated we can be in the gathering of public health information,” he said in a separate interview for this article, “the clearer the picture we’ll have of the crisis and how to fight it!”

A Shared Mission on Data Integrity

Against the backdrop of inadequate national and international coordination I mentioned earlier, the takeaway is clear: It’s up to each of us as technology providers to model leading practices on data integrity and harmonization wherever we see an opportunity – to pilot approaches and socialize the success stories.

As just one example, you may pilot ways to align various standards and protocols you encounter with a master data management approach that’s enhanced and tailored for COVID-19 analysis. Chief among your goals should be to establish a clear understanding of the core data entities and any relevant context: Is it imaging or genomics data? Is it information about a diagnostic or an antibody test? Was the personal health data collected legally/ethically, and therefore is usable?

Grasping these differences will help align our management of data as we navigate the collective, global IT cause against COVID-19 and all future public health threats. The more we as technology providers support this alignment toward our shared mission, the more effective our efforts will be to support the response and save lives.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Tilray® Increases Cannabis Supply with Acquisition of Natura Naturals HoldingsTilray® Increases Cannabis Supply with Acquisition of Natura Naturals Holdings
  • Digital MSK Company SWORD Health Launches Product Aimed at Female Pelvic PainDigital MSK Company SWORD Health Launches Product Aimed at Female Pelvic Pain
  • Relay Medical Closes Acquisition of IoT Cybersecurity Firm, Cybeats Technologies Inc.Relay Medical Closes Acquisition of IoT Cybersecurity Firm, Cybeats Technologies Inc.
  • Owlet Smart Baby Monitor to Go Public in SPAC IPO DealOwlet Smart Baby Monitor to Go Public in SPAC IPO Deal
  • Teladoc Health Expands Into Personalized Nutrition Counseling with Launch of Teladoc NutritionTeladoc Health Expands Into Personalized Nutrition Counseling with Launch of Teladoc Nutrition
  • Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable BandageImbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage
  • Notable Launches Observational Clinical Trial for Patients with Blood CancerNotable Launches Observational Clinical Trial for Patients with Blood Cancer
  • Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics PlatformBiofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications